Insider Transactions Reported by 18 Insiders of Coherus Oncology, Inc.

Symbol
CHRS on Nasdaq
Location
Redwood City, CA

Insiders trading volume in the past year

Coherus Oncology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dennis M. Lanfear President & CEO, Director $2,226,394 23 Jan 2026
Vincent R. Anicetti Chief Operating Officer $304,488 06 Jul 2021
Vladimir Vexler Chief Scientific Officer $283,921 31 Mar 2023
Bryan J. McMichael Chief Financial Officer $189,905 22 Jan 2026
McDavid Stilwell Chief Financial Officer $183,744 31 Dec 2023
Paul Reider Chief Commercial Officer $114,076 20 Jan 2025
Mats Wahlstrom Director $0 -$73,881 -100% 12 Jun 2025
JAMES HEALY Director 07 Jan 2022
MARK STOLPER Director 03 Jun 2024
ALAN C. MENDELSON Director 21 May 2021
KIMBERLY JO TZOUMAKAS Director 03 Jun 2024
Michael Lee Ryan Director 12 Jun 2025
Georgia Erbez Director 12 Jun 2025
Ali J. Satvat Director 12 Jun 2025
Charles W. Newton Director 12 Jun 2025
Jill O'Donnell-Tormey Director 12 Jun 2025
Rita A. Karachun Director 12 Jun 2025
Lee Nisley Newcomer Director 12 Jun 2025

Recent Insider Transactions by Companies or Individuals for Coherus Oncology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.